• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model.抑制可溶性环氧化物水解酶对链脲佐菌素诱导的糖尿病小鼠模型葡萄糖稳态和胰岛损伤的有益作用。
Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:42-8. doi: 10.1016/j.prostaglandins.2012.12.001. Epub 2012 Dec 13.
2
Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.抑制或删除可溶性环氧化物水解酶可预防高血糖,促进胰岛素分泌,并减少胰岛细胞凋亡。
J Pharmacol Exp Ther. 2010 Aug;334(2):430-8. doi: 10.1124/jpet.110.167544. Epub 2010 May 3.
3
Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.可溶性环氧化物水解酶在链脲佐菌素诱导的 1 型糖尿病加重中风中的作用。
J Cereb Blood Flow Metab. 2013 Oct;33(10):1650-6. doi: 10.1038/jcbfm.2013.130. Epub 2013 Jul 31.
4
Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.基因敲除可溶性环氧化物水解酶可预防链脲佐菌素诱导的糖尿病肾病。
Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E563-75. doi: 10.1152/ajpendo.00591.2011. Epub 2012 Jun 26.
5
Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.血红素加氧酶在可溶性环氧化物水解酶抑制物对糖尿病自发性高血压大鼠肾脏保护作用中的作用。
Clin Sci (Lond). 2013 Oct;125(7):349-59. doi: 10.1042/CS20130003.
6
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.可溶性环氧化物水解酶抑制可改善肥胖胰岛素抵抗小鼠的冠状动脉内皮功能,并预防心脏病变的发展。
Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1020-9. doi: 10.1152/ajpheart.00465.2014. Epub 2015 Feb 27.
7
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.可溶性环氧化物水解酶缺乏改变胰岛大小,并改善胰岛素抵抗模型中的葡萄糖稳态。
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9038-43. doi: 10.1073/pnas.1103482108. Epub 2011 May 12.
8
Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke.2型糖尿病性中风中可溶性环氧化物水解酶抑制的保护机制
PLoS One. 2014 May 13;9(5):e97529. doi: 10.1371/journal.pone.0097529. eCollection 2014.
9
Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.美洛昔康不能通过提高20-羟基二十碳四烯酸(20-HETE)水平来增强可溶性环氧化物水解酶抑制对链脲佐菌素诱导的糖尿病大鼠的肾脏保护作用。
Prostaglandins Other Lipid Mediat. 2017 Sep;132:3-11. doi: 10.1016/j.prostaglandins.2016.08.004. Epub 2016 Sep 3.
10
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.可溶性环氧化物水解酶抑制对高血糖超重小鼠早期肾损伤的影响
Prostaglandins Other Lipid Mediat. 2015 Jul;120:148-54. doi: 10.1016/j.prostaglandins.2015.04.011. Epub 2015 May 27.

引用本文的文献

1
GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans.GSK2256294 降低人血浆、肌肉和脂肪中的 sEH(可溶性环氧化物水解酶)活性,并降低 F2-异前列腺素,但不改变胰岛素敏感性。
Hypertension. 2021 Sep;78(4):1092-1102. doi: 10.1161/HYPERTENSIONAHA.121.17659. Epub 2021 Aug 30.
2
Genetic deficiency or pharmacological inhibition of soluble epoxide hydrolase ameliorates high fat diet-induced pancreatic β-cell dysfunction and loss.遗传缺陷或药理学抑制可溶性环氧化物水解酶可改善高脂肪饮食诱导的胰腺β细胞功能障碍和丧失。
Free Radic Biol Med. 2021 Aug 20;172:48-57. doi: 10.1016/j.freeradbiomed.2021.05.029. Epub 2021 May 24.
3
Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.从化学合成和天然产物中发现可溶性环氧化物水解酶抑制剂
J Med Chem. 2021 Jan 14;64(1):184-215. doi: 10.1021/acs.jmedchem.0c01507. Epub 2020 Dec 28.
4
A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage.可溶性环氧化物水解酶与 AT1 受体在视网膜微血管损伤中的新相互作用。
Prostaglandins Other Lipid Mediat. 2020 Jun;148:106449. doi: 10.1016/j.prostaglandins.2020.106449. Epub 2020 Apr 30.
5
MicroRNA-133a impairs perfusion recovery after hindlimb ischemia in diabetic mice.微小 RNA-133a 损害糖尿病小鼠后肢缺血后灌注的恢复。
Biosci Rep. 2018 Jul 2;38(4). doi: 10.1042/BSR20180346. Print 2018 Aug 31.
6
Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.条件性敲除和过表达小鼠胰岛β细胞中的 E2 SUMO 连接酶(UBC9)均导致β细胞功能受损。
Diabetologia. 2018 Apr;61(4):881-895. doi: 10.1007/s00125-017-4523-9. Epub 2018 Jan 3.
7
Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.调节线粒体功能障碍和内质网应激是环氧脂肪酸和可溶性环氧水解酶抑制剂广泛作用的关键机制。
Prostaglandins Other Lipid Mediat. 2017 Nov;133:68-78. doi: 10.1016/j.prostaglandins.2017.08.003. Epub 2017 Aug 25.
8
Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.足细胞中的可溶性环氧化物水解酶在高血糖状态下对肾功能有重要贡献。
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2758-2765. doi: 10.1016/j.bbagen.2017.07.021. Epub 2017 Jul 27.
9
CYP2J2 and Its Metabolites EETs Attenuate Insulin Resistance via Regulating Macrophage Polarization in Adipose Tissue.CYP2J2 及其代谢产物 EETs 通过调节脂肪组织中巨噬细胞极化来减轻胰岛素抵抗。
Sci Rep. 2017 Apr 25;7:46743. doi: 10.1038/srep46743.
10
Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.可溶性环氧化物水解酶抑制剂可将正常、高血压和糖尿病大鼠缺血再灌注引起的心脏损伤降至最低。
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12259.

本文引用的文献

1
Role of epoxide hydrolases in lipid metabolism.环氧水解酶在脂代谢中的作用。
Biochimie. 2013 Jan;95(1):91-5. doi: 10.1016/j.biochi.2012.06.011. Epub 2012 Jun 18.
2
Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.可溶性环氧化物水解酶抑制、环氧化脂肪酸和痛觉。
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):76-83. doi: 10.1016/j.prostaglandins.2011.08.001. Epub 2011 Aug 10.
3
Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.可溶性环氧化物水解酶基因缺失可改善链脲佐菌素诱导的 1 型糖尿病大鼠肾脏内皮功能,并减轻其肾脏炎症和损伤。
Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1307-17. doi: 10.1152/ajpregu.00759.2010. Epub 2011 Aug 10.
4
Eicosanoids, β-cell function, and diabetes.类二十烷酸、β 细胞功能与糖尿病。
Prostaglandins Other Lipid Mediat. 2011 Aug;95(1-4):1-10. doi: 10.1016/j.prostaglandins.2011.06.001. Epub 2011 Jul 3.
5
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.可溶性环氧化物水解酶缺乏改变胰岛大小,并改善胰岛素抵抗模型中的葡萄糖稳态。
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9038-43. doi: 10.1073/pnas.1103482108. Epub 2011 May 12.
6
Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects.AR9281 是一种可溶性环氧化物水解酶抑制剂,在健康人体单剂量和多剂量研究中的药代动力学和药效学。
J Clin Pharmacol. 2012 Mar;52(3):319-28. doi: 10.1177/0091270010397049. Epub 2011 Mar 21.
7
Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.肥胖相关的骨骼肌胰岛素抵抗:脂肪堆积和体力活动不足的作用。
Rev Endocr Metab Disord. 2011 Sep;12(3):163-72. doi: 10.1007/s11154-011-9168-2.
8
Obesity, insulin resistance and free fatty acids.肥胖、胰岛素抵抗和游离脂肪酸。
Curr Opin Endocrinol Diabetes Obes. 2011 Apr;18(2):139-43. doi: 10.1097/MED.0b013e3283444b09.
9
Stability and analysis of eicosanoids and docosanoids in tissue culture media.组织培养液中类二十烷酸和类二十二烷酸的稳定性及分析。
Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):59-72. doi: 10.1016/j.prostaglandins.2011.01.003. Epub 2011 Jan 12.
10
Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.抑制或删除可溶性环氧化物水解酶可预防高血糖,促进胰岛素分泌,并减少胰岛细胞凋亡。
J Pharmacol Exp Ther. 2010 Aug;334(2):430-8. doi: 10.1124/jpet.110.167544. Epub 2010 May 3.

抑制可溶性环氧化物水解酶对链脲佐菌素诱导的糖尿病小鼠模型葡萄糖稳态和胰岛损伤的有益作用。

Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model.

机构信息

Department of Physiology, Georgia Health Sciences University, Augusta, GA 30912, USA.

出版信息

Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:42-8. doi: 10.1016/j.prostaglandins.2012.12.001. Epub 2012 Dec 13.

DOI:10.1016/j.prostaglandins.2012.12.001
PMID:23247129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4052893/
Abstract

Soluble epoxide hydrolase (sEH) is an enzyme involved in the metabolism of endogenous inflammatory and anti-apoptotic mediators. In the present study, we determined the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chemical-induced diabetes. STZ increased daily water intake and decreased visceral (spleen and pancreas) weight in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral weight. Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH. The beneficial effects of sEH inhibition were accompanied, after 2 and 4 weeks of initial administration, by improving glucose tolerance. In contrast, sEH inhibition did not affect insulin tolerance. Using LC/MS analysis, neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels. Western blot analysis showed that mouse cytochrome P450 (CYP) 2C enzymes are the major epoxygenases in islets. On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis. These studies provide pharmacological evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.

摘要

可溶性环氧化物水解酶(sEH)是一种参与内源性炎症和抗细胞凋亡介质代谢的酶。在本研究中,我们确定了抑制 sEH 对链脲佐菌素(STZ)处理的小鼠葡萄糖稳态和胰岛损伤的影响,STZ 是一种化学诱导型糖尿病模型。STZ 增加了小鼠的日饮水量并降低了内脏(脾脏和胰腺)重量;sEH 抑制可减少 STZ 小鼠的饮水量,但不影响内脏重量。sEH 抑制可减轻 STZ 处理诱导的小鼠高血糖。在初始给药 2 周和 4 周后,sEH 抑制的有益作用伴随着葡萄糖耐量的改善。相比之下,sEH 抑制并不影响胰岛素耐量。通过 LC/MS 分析,无论是 STZ 还是 STZ 加 sEH 抑制均未影响胰腺和血浆中环氧化物水解酶(EETs)与二羟环氧化物水解酶(DHETs)的比值,这是 EETs 水平的一个指标。Western blot 分析表明,小鼠细胞色素 P450(CYP)2C 酶是胰岛中的主要环氧化物酶。在初次 STZ 处理后的第 5 天,STZ 诱导胰岛细胞凋亡,而 sEH 抑制可显著减少 STZ 小鼠的胰岛细胞凋亡。这些研究提供了药理学证据,表明抑制 sEH 活性可显著保护胰岛 β 细胞免受损伤,并改善 STZ 诱导的糖尿病中的葡萄糖稳态。